FDA approves Darzalex in combination with standard of care for relapsed multiple myeloma Nov. 22, 2016
European Commission approves Trisenox for first-line treatment of low to intermediate risk APL Nov. 21, 2016
European approval for Parsabiv to treat secondary hyperparathyroidism in hemodialysis patients Nov. 14, 2016
RSS